Key | % Net Assets |
---|---|
Royal Dutch Shell Plc 'B' | 6.8% |
BG Group Plc | 6.3% |
GlaxoSmithKline Plc | 5.9% |
Vodafone Group Plc | 4.8% |
Other | 76.2% |
Name | % Net Assets |
---|---|
Royal Dutch Shell Plc 'B' | 6.8% |
BG Group Plc | 6.3% |
GlaxoSmithKline Plc | 5.9% |
Vodafone Group Plc | 4.8% |
Anglo American Plc | 4.8% |
Unilever Plc | 4.8% |
BP Plc | 4.2% |
Centrica Plc | 3.6% |
HSBC Holdings | 3.3% |
AstraZeneca Plc | 2.6% |
No asset data available.
Date | 03-Mar-2010 |
---|---|
NAV | 139.40p |
Currency | GBP |
Change | 3.30p |
% | 2.42% |
YTD change | 139.40p |
YTD % | n/a |
Fund Inception | 01/11/1999 |
---|---|
Fund Manager | Jeremy Smith |
TER | - |
Minimum Investment | |
---|---|
Initial | £500000 |
Additional | n/a |
Savings | n/a |
Charges | |
---|---|
Initial | 3.00% |
Annual Mang't | 0.50% |
Exit | n/a |
Name | % |
---|---|
Standard deviation | 0.01 |
Sharpe ratio | 0.08 |
You are here: research